Cargando…

IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes

Detalles Bibliográficos
Autores principales:	Murtas, Daniela, Maric, Dragan, De Giorgi, Valeria, Reinboth, Jennifer, Worschech, Andrea, Fetsch, Patricia, Filie, Armando, Ascierto, Maria Libera, Bedognetti, Davide, Liu, Qiuzhen, Uccellini, Lorenzo, Chouchane, Lotfi, Wang, Ena, Marincola, Francesco M, Tomei, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990328/ http://dx.doi.org/10.1186/2051-1426-1-S1-P249

Ejemplares similares

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
por: Murtas, D, et al.
Publicado: (2013)

The immune‐related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2014)

The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015)

The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012)

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population
por: Tomei, Sara, et al.
Publicado: (2012)

IRF5 gene polymorphisms in melanoma
por: Uccellini, Lorenzo, et al.
Publicado: (2012)

An immunologic portrait of cancer
por: Ascierto, Maria Libera, et al.
Publicado: (2011)

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68
por: Ascierto, Maria Libera, et al.
Publicado: (2011)

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
por: Spivey, Tara L, et al.
Publicado: (2011)

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
por: Al Hashmi, Muna, et al.
Publicado: (2020)

NGS technology applied to melanoma cell lines
por: De Giorgi, Valeria, et al.
Publicado: (2013)

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
por: Gowda, Madhu, et al.
Publicado: (2011)

Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling
por: Sastry, Konduru S, et al.
Publicado: (2017)

A genetic inference on cancer immune responsiveness
por: Wang, Ena, et al.
Publicado: (2012)

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
por: Ascierto, Maria Libera, et al.
Publicado: (2013)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
por: De Giorgi, Valeria, et al.
Publicado: (2013)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy
por: Sommariva, Michele, et al.
Publicado: (2013)

GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8(+ )T cells
por: Selleri, Silvia, et al.
Publicado: (2008)

Genomic scale analysis of NK cells impact on response to IFN-α
por: Ascierto, Maria L, et al.
Publicado: (2013)

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection
por: Panelli, Monica C, et al.
Publicado: (2007)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
por: Bedognetti, D, et al.
Publicado: (2013)

IRF3 and IRF7 mediate neovascularization via inflammatory cytokines
por: Simons, Karin H., et al.
Publicado: (2019)

Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection
por: Weibel, Stephanie, et al.
Publicado: (2011)

Reflections upon human cancer immune responsiveness to T cell-based therapy
por: Wang, Ena, et al.
Publicado: (2012)

Intradermal influenza vaccination in complete remission cancer patients: molecular insights
por: Bedognetti, Davide, et al.
Publicado: (2013)

Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?
por: Mégarbané, André, et al.
Publicado: (2016)

Toward the identification of genetic determinants of breast cancer immune responsiveness
por: Simeone, Ines, et al.
Publicado: (2015)

Polarized monocyte response to cytokine stimulation
por: Nagorsen, Dirk, et al.
Publicado: (2005)

Erratum to: Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome
por: Haidar, Zahraa, et al.
Publicado: (2017)

Diagnosis implications of the whole genome sequencing in a large Lebanese family with hyaline fibromatosis syndrome
por: Haidar, Zahraa, et al.
Publicado: (2017)

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon
por: Wang, Ena, et al.
Publicado: (2012)

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
por: Panelli, Monica C, et al.
Publicado: (2004)

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
por: Bedognetti, Davide, et al.
Publicado: (2011)

Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology
por: Pos, Zoltan, et al.
Publicado: (2013)

Associations between HLA Class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians
por: Li, Xin, et al.
Publicado: (2007)

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
por: Shan, Jingxuan, et al.
Publicado: (2019)

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
por: Roelands, Jessica, et al.
Publicado: (2017)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7kmi0su8jhdonuhks4b2pi0b5n